Aims: To evaluate the diagnostic accuracy of Claude-3, a large language model, in detecting pathological features and diagnosing retinitis pigmentosa and cone-rod dystrophy using pattern electroretinography data.
Methods: A subset of pattern electroretinography measurements from healthy individuals, patients with retinitis pigmentosa and cone-rod dystrophy was randomly selected from the PERG-IOBA dataset. The pattern electroretinography and clinical data, including age, gender, visual acuities, were provided to Claude-3 for analysis and diagnostic predictions. The model’s accuracy was assessed in two scenarios: “first choice,” evaluating the accuracy of the primary differential diagnosis and “top 3,” evaluating whether the correct diagnosis was included within the top three differential diagnoses.
Results: A total of 46 subjects were included in the study: 20 healthy individuals, 13 patients with retinitis pigmentosa, 13 patients with cone-rod dystrophy. Claude-3 achieved 100% accuracy in detecting the presence or absence of pathology. In the “first choice” scenario, the model demonstrated moderate accuracy in diagnosing retinitis pigmentosa (61.5%) and cone-rod dystrophy (53.8%). However, in the “top 3” scenario, the model’s performance significantly improved, with accuracies of 92.3% for retinitis pigmentosa and 76.9% for cone-rod dystrophy.
Conclusion: This is the first study to demonstrate the potential of large language models, specifically Claude-3, in analyzing pattern electroretinography data to diagnose retinal disorders. Despite some limitations, the model’s high accuracy in detecting pathologies and distinguishing between specific diseases highlights the potential of large language models in ocular electrophysiology. Future research should focus on integrating multimodal data, and conducting comparative analyses with human experts.
Ethics Committee Approval: Since the PERG IOBA dataset from the PhysioNet database was used in this study, ethical approval is not required. The terms of use of the database have been adhered to. Informed Consent: Because the study was designed retrospectively, no written informed consent form was obtained from patients. Referee Evaluation Process: Externally peer-reviewed. Conflict of Interest Statement: The authors have no conflicts of interest to declare. Financial Disclosure: The authors declared that this study has received no financial support. Author Contributions: All of the authors declare that they have all participated in the design, execution, and analysis of the paper, and that they have approved the final version. Acknowledgement: Our research’s data was presented in ‘15th Medical Informatics Congress’ as ‘Oral Presentation’ on May 30, 2024.
Primary Language | English |
---|---|
Subjects | Ophthalmology |
Journal Section | Original Article |
Authors | |
Publication Date | September 27, 2024 |
Submission Date | June 28, 2024 |
Acceptance Date | August 30, 2024 |
Published in Issue | Year 2024 Volume: 7 Issue: 5 |
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.